ID   14F7
AC   CVCL_XI29
DR   Wikidata; Q93299302
RX   Patent=US6429295;
RX   PubMed=10952412;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, European Collection of Cell Cultures (ECACC); 98101901.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: ChEBI; CHEBI:144806; N-glycolylneuraminyllactosylceramide (GM3(NeuGc); HD3 ganglioside).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 19-12-19; Last updated: 30-01-24; Version: 4
//
RX   Patent=US6429295;
RA   Carr-Perez A., Mazorra-Herrera Z., Fernandez-Molina L.E.,
RA   Vazquez-Lopez A.M., Mulet-Sierra A., Perez-Rodriguez R.;
RT   "Monoclonal antibody which recognizes the oligosaccharide N-
RT   glycolylated-galactose-glucose sialic acid in malignant tumors, and
RT   composition containing it.";
RL   Patent number US6429295, 06-Aug-2002.
//
RX   PubMed=10952412; DOI=10.1089/02724570050109639;
RA   Carr-Perez A., Mulet-Sierra A., Mazorra-Herrera Z., Vazquez-Lopez A.M.,
RA   Alfonso M., Mesa C., Rengifo-Calzado E., Perez-Rodriguez R.,
RA   Fernandez-Molina L.E.;
RT   "A mouse IgG1 monoclonal antibody specific for N-glycolyl GM3
RT   ganglioside recognized breast and melanoma tumors.";
RL   Hybridoma 19:241-247(2000).
//